Drugs associated with nonimmune thrombocytopenia
| Suspected impaired thrombopoiesis . | Suspected proapoptotic effect . |
|---|---|
| Chemotherapy | Tamoxifen |
| Antineoplastics | Navitoclax |
| Interferon-a | Methotrexate |
| Linezolid | Nuclear factor–κB inhibitors |
| Botrezomib | Lovastatin |
| Thiazide diuretics | Doxorubicin |
| Ethanol | Bexarotene |
| Tolbutamid | Arsenic trioxide |
| Ganciclovir | Aspirin |
| Vancomycin | |
| Trifluoperazine | |
| Balhimycin | |
| Carmustine | |
| ABT-737 | |
| Cisplatin |
| Suspected impaired thrombopoiesis . | Suspected proapoptotic effect . |
|---|---|
| Chemotherapy | Tamoxifen |
| Antineoplastics | Navitoclax |
| Interferon-a | Methotrexate |
| Linezolid | Nuclear factor–κB inhibitors |
| Botrezomib | Lovastatin |
| Thiazide diuretics | Doxorubicin |
| Ethanol | Bexarotene |
| Tolbutamid | Arsenic trioxide |
| Ganciclovir | Aspirin |
| Vancomycin | |
| Trifluoperazine | |
| Balhimycin | |
| Carmustine | |
| ABT-737 | |
| Cisplatin |